You are here

  • Home
  • Archive
  • Volume 13, Issue 2
  • Review: corticosteroids plus long-acting β-agonists reduce exacerbations more than long-acting β-agonists alone in COPD

Article Text

Article menu
Download PDFPDF
Therapeutics
Review: corticosteroids plus long-acting β-agonists reduce exacerbations more than long-acting β-agonists alone in COPD

https://doi.org/10.1136/ebm.13.2.57

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    L J Nannini

    Dr L J Nannini, Hospital G. Baigorria, Santa Fe-Rosario, Argentina; nanninilj@cimero.org.ar

    REVIEW PROCESS

    Question:

    in patients with stable chronic obstructive pulmonary disease (COPD), how do inhaled corticosteroids (ICSs) combined with long-acting β-agonists (LABAs) compare with LABAs alone?

    Search methods:

    Medline, EMBASE/Excerpta Medica, Cochrane Central Register of Controlled Trials, Cochrane Library (Issue 1, 2007), Cochrane Airways Group Specialised Register, 4 other databases, …

    View Full Text

    Footnotes

    • Source of funding: not stated.